VENUS REMEDIES
Back to Income Statement
|
VENUS REMEDIES Last 5 Year Revenue History
[Consolidated]
Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|---|
Net Sales | ₹648 Cr | ₹601 Cr | ₹556 Cr | ₹600 Cr | ₹548 Cr |
What is the latest Revenue of VENUS REMEDIES ?
Year | Revenue |
---|---|
Mar2025 | ₹648 Cr |
Mar2024 | ₹601 Cr |
Mar2023 | ₹556 Cr |
Mar2022 | ₹600 Cr |
Mar2021 | ₹548 Cr |
How is Revenue of VENUS REMEDIES Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2025 | ₹648 Cr | 7.72 | |
Mar2024 | ₹601 Cr | 8.27 | |
Mar2023 | ₹556 Cr | -7.44 | |
Mar2022 | ₹600 Cr | 9.50 | |
Mar2021 | ₹548 Cr | - |
Compare Revenue of peers of VENUS REMEDIES
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
VENUS REMEDIES | ₹682.1 Cr | -2.6% | 17.9% | 23.2% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹391,607.0 Cr | -5.9% | -2.8% | -5.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹170,148.0 Cr | -3.7% | -6.9% | 30.1% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,471.0 Cr | -3.8% | 7.1% | 12% | Stock Analytics | |
CIPLA | ₹121,103.0 Cr | -3.9% | -0.8% | -0.9% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹101,306.0 Cr | -6% | -7.3% | -12% | Stock Analytics |
VENUS REMEDIES Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
VENUS REMEDIES | -2.6% |
17.9% |
23.2% |
SENSEX | -0.8% |
-3.3% |
-1.4% |
You may also like the below Video Courses